Catalogue identityDataset 2026.08.15.1

Profhilo Structura

IBSA

This is the Profhilo Structura identity captured in the dated Aesthetic Pass operational catalogue snapshot. Product-specific source verification is available at family level only.

Evidence status: Catalogue identity · family sources available

The clinical research edition

Go deeper into the formulation and evidence

Explore composition, mechanism, safety and study interpretations for the exact presentation below. These new clinical drafts have a separate review process; this identity profile’s approval does not extend to them.

Profhilo 3.2% · 2 ml monograph ↗

Identity record

What is recorded

v2026.08.15.1
Record type
Operational catalogue identity
Recorded maker
IBSA
Classification
Skin booster / biostimulator
Material identity
Not recorded in this snapshot
Snapshot date
15 August 2026

Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.

Family evidence available

This identity maps to Profhilo

The family profile provides aliases and official family-level sources. Those sources do not automatically verify this exact variant, formulation, label, or market status.

Open family profile

Provenance

Family-level sources

4 sources · checked 15 August 2026

These sources support the linked family profile, not every property of this exact catalogue identity.

  1. Manufacturer

    1. Profhilo product line

    IBSA Derma · International overview

    Open source ↗

    Supports: Profhilo family identity and hyaluronic-acid material class.

  2. Manufacturer

    2. Profhilo — Face & Neck

    IBSA Germany · Germany

    Open source ↗

    Supports: German manufacturer product listing and local product-information context.

  3. Regulator

    3. PROFHILO 3.2% — ARTG 387132

    Australian Therapeutic Goods Administration · Australia

    Open source ↗

    Supports: The active Australian Class III medical-device record for the named PROFHILO 3.2%, 32 mg H-HA plus 32 mg L-HA per 2 ml presentation and its manufacturer.

  4. Instructions for use

    4. Profhilo — Australian Instructions for Use

    IBSA Farmaceutici Italia / IBSA Derma Australia · Australia

    Open source ↗

    Supports: The product-specific Profhilo identity, 2 ml presentation, sodium-hyaluronate composition, professional-use context, precautions, and adverse-event wording for the attached Australian IFU.

Use boundary

What this record does not establish

  • Regulatory statusOnly within a source's named jurisdiction; family evidence does not establish status elsewhere.
  • Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
  • Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
  • Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.

Separate reference from record-keeping

Document the exact product and lot actually used

Aesthetic Pass records treatment identity, lot information, photos, and injection maps. The atlas itself never chooses a product or treatment.

Explore traceability